Skip to main content

David Wasserman Archives

Insulin accelerant

Oct. 16, 2018—Reducing nitric oxide helps insulin move more quickly through blood vessels, find David Wasserman and colleagues.

Read more


Team’s findings could spur new treatments for type 2 diabetes

Sep. 6, 2018—New research by an international team that includes Vanderbilt researchers shows how a common diabetes drug blocks glucose production by the liver, suggesting new avenues for treatment.

Read more


Faculty meeting recognizes excellence in education, research and clinical service

May. 24, 2018—During Wednesday’s Spring Faculty Meeting, Jeff Balser, M.D., Ph.D., dean of Vanderbilt University School of Medicine and President and CEO of Vanderbilt University Medical Center, highlighted the medical school’s rising stature among the country’s top-tier institutions.

Read more


Voluntary exercise and energy balance

Mar. 23, 2018—Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.

Read more


Study may point to new ways to reverse insulin resistance

Jan. 25, 2018—Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.

Read more


15 faculty members elected as AAAS fellows

Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

Read more


Phenotyping center a global resource for investigators

Nov. 16, 2017—This summer the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC) began its 17th year of continuous operation and federal support with a $5.5 million, five-year renewal grant from the National Institutes of Health (NIH).

Read more


Study spots possible new approach to prevent obesity

Apr. 14, 2016—An international research team that included scientists from Vanderbilt University Medical Center has found a novel way to counteract obesity in mice — by stimulating the growth of blood vessels in fat tissue.

Read more


Photo: Mouse Metabolic Phenotyping Center

Jun. 25, 2015—David Wasserman, Ph.D., kicks off Wednesday’s ribbon cutting and open house to celebrate the newly renovated Mouse Metabolic Phenotyping Center (MMPC) on the eighth floor of Light Hall. The center, founded in 2001, provides novel techniques for studying mouse models of diabetes and other metabolic disorders. As measured by the scientific papers that flow out...

Read more


Matrix remodeling and insulin resistance

Apr. 10, 2014—The extracellular matrix that surrounds cells plays a role in the development of insulin resistance.

Read more


Relaxin combats insulin resistance

Oct. 16, 2013—The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance.

Read more


Matrix member key to insulin resistance

Jun. 6, 2013—A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target.

Read more


Page 1 of 212

Upcoming Events

MORE EVENTS »